Chenguang Biotech Group (300138) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.155x

Based on the latest financial reports, Chenguang Biotech Group (300138) has a cash flow conversion efficiency ratio of 0.155x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥524.96 Million ≈ $76.82 Million USD) by net assets (CN¥3.39 Billion ≈ $495.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Chenguang Biotech Group balance sheet independence to measure how much of total assets are equity-financed.

Chenguang Biotech Group - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Chenguang Biotech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300138 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Chenguang Biotech Group Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chenguang Biotech Group ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Air New Zealand Ltd AU:AIZ	0.117x
Bain Capital Specialty Finance Inc NYSE:BCSF	0.021x
Bangkok Chain Hospital Public Company Limited BK:BCH	0.050x
Cresud SA BA:CRES	-0.021x
Logwin AG XETRA:TGHN	0.123x
Solareast Holdings Co Ltd SHG:603366	0.015x
AB SKF (publ) ST:SKF-A	-0.008x
Jutze Intelligent Technology Co Ltd SHE:300802	0.021x

Annual Cash Flow Conversion Efficiency for Chenguang Biotech Group (2007–2024)

The table below shows the annual cash flow conversion efficiency of Chenguang Biotech Group from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see Chenguang Biotech Group market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.15 Billion ≈ $461.63 Million	CN¥-222.81 Million ≈ $-32.60 Million	-0.071x	+51.17%
2023-12-31	CN¥3.53 Billion ≈ $516.88 Million	CN¥-510.91 Million ≈ $-74.76 Million	-0.145x	-163.27%
2022-12-31	CN¥3.21 Billion ≈ $470.32 Million	CN¥734.81 Million ≈ $107.53 Million	0.229x	+895.84%
2021-12-31	CN¥2.78 Billion ≈ $407.30 Million	CN¥63.90 Million ≈ $9.35 Million	0.023x	-91.07%
2020-12-31	CN¥2.06 Billion ≈ $301.37 Million	CN¥529.41 Million ≈ $77.47 Million	0.257x	+1938.29%
2019-12-31	CN¥1.74 Billion ≈ $254.77 Million	CN¥-24.35 Million ≈ $-3.56 Million	-0.014x	+56.69%
2018-12-31	CN¥1.74 Billion ≈ $254.64 Million	CN¥-56.18 Million ≈ $-8.22 Million	-0.032x	+64.08%
2017-12-31	CN¥1.62 Billion ≈ $237.63 Million	CN¥-145.95 Million ≈ $-21.36 Million	-0.090x	+57.39%
2016-12-31	CN¥1.52 Billion ≈ $223.15 Million	CN¥-321.62 Million ≈ $-47.06 Million	-0.211x	-365.52%
2015-12-31	CN¥1.43 Billion ≈ $208.84 Million	CN¥-64.66 Million ≈ $-9.46 Million	-0.045x	-116.74%
2014-12-31	CN¥1.01 Billion ≈ $147.58 Million	CN¥272.96 Million ≈ $39.94 Million	0.271x	+835.08%
2013-12-31	CN¥990.39 Million ≈ $144.93 Million	CN¥-36.47 Million ≈ $-5.34 Million	-0.037x	+74.15%
2012-12-31	CN¥997.86 Million ≈ $146.02 Million	CN¥-142.11 Million ≈ $-20.79 Million	-0.142x	-267.87%
2011-12-31	CN¥968.71 Million ≈ $141.75 Million	CN¥82.18 Million ≈ $12.03 Million	0.085x	+141.55%
2010-12-31	CN¥933.05 Million ≈ $136.53 Million	CN¥-190.51 Million ≈ $-27.88 Million	-0.204x	-257.95%
2009-12-31	CN¥210.67 Million ≈ $30.83 Million	CN¥27.23 Million ≈ $3.99 Million	0.129x	+111.04%
2008-12-31	CN¥147.93 Million ≈ $21.65 Million	CN¥9.06 Million ≈ $1.33 Million	0.061x	+127.06%
2007-12-31	CN¥101.70 Million ≈ $14.88 Million	CN¥-23.02 Million ≈ $-3.37 Million	-0.226x	--

About Chenguang Biotech Group

SHE:300138 China Farm Products

Market Cap

$823.57 Million

CN¥5.63 Billion CNY

Market Cap Rank

#9664 Global

#2444 in China

Share Price

CN¥11.65

Change (1 day)

+0.09%

52-Week Range

CN¥8.94 - CN¥15.71

All Time High

CN¥19.02